145 related articles for article (PubMed ID: 22860991)
21. Melatonin: from biochemistry to therapeutic applications.
Zawilska JB; Nowak JZ
Pol J Pharmacol; 1999; 51(1):3-23. PubMed ID: 10389140
[TBL] [Abstract][Full Text] [Related]
22. Localization and biological activities of melatonin in intact and diseased gastrointestinal tract (GIT).
Konturek SJ; Konturek PC; Brzozowska I; Pawlik M; Sliwowski Z; Cześnikiewicz-Guzik M; Kwiecień S; Brzozowski T; Bubenik GA; Pawlik WW
J Physiol Pharmacol; 2007 Sep; 58(3):381-405. PubMed ID: 17928638
[TBL] [Abstract][Full Text] [Related]
23. Human circadian rhythms: physiological and therapeutic relevance of light and melatonin.
Skene DJ; Arendt J
Ann Clin Biochem; 2006 Sep; 43(Pt 5):344-53. PubMed ID: 17022876
[TBL] [Abstract][Full Text] [Related]
24. Melatonin receptors in brain areas and ocular tissues of the teleost Tinca tinca: characterization and effect of temperature.
López Patiño MA; Alonso-Gómez AL; Guijarro A; Isorna E; Delgado MJ
Gen Comp Endocrinol; 2008 Feb; 155(3):847-56. PubMed ID: 18177872
[TBL] [Abstract][Full Text] [Related]
25. Melatonin-synthesizing enzymes in pineal, retina, liver, and gut of the goldfish (Carassius): mRNA expression pattern and regulation of daily rhythms by lighting conditions.
Velarde E; Cerdá-Reverter JM; Alonso-Gómez AL; Sánchez E; Isorna E; Delgado MJ
Chronobiol Int; 2010 Jul; 27(6):1178-201. PubMed ID: 20653449
[TBL] [Abstract][Full Text] [Related]
26. [Development of animal models for the chronobiotics of melatonin analogs].
Guardiola-Lemaître B
Therapie; 1998; 53(5):439-44. PubMed ID: 9921035
[TBL] [Abstract][Full Text] [Related]
27. [Melatonin, synthetic analogs, and the sleep/wake rhythm].
Escames G; Acuña-Castroviejo D
Rev Neurol; 2009 Mar 1-15; 48(5):245-54. PubMed ID: 19263393
[TBL] [Abstract][Full Text] [Related]
28. The Role and Therapeutic Potential of Melatonin in Degenerative Fundus Diseases: Diabetes Retinopathy and Age-Related Macular Degeneration.
Ma C; Li H; Lu S; Li X
Drug Des Devel Ther; 2024; 18():2329-2346. PubMed ID: 38911030
[TBL] [Abstract][Full Text] [Related]
29. Ocular actions of platelet-activating factor: clinical implications.
Nitoda E; Moschos MM; Mavragani CP; Koutsilieris M
Expert Opin Ther Targets; 2012 Oct; 16(10):1027-39. PubMed ID: 22924390
[TBL] [Abstract][Full Text] [Related]
30. The aging eye and the role of L-carnitine and its derivatives.
Pescosolido N; Imperatrice B; Karavitis P
Drugs R D; 2008; 9 Suppl 1():3-14. PubMed ID: 19105587
[TBL] [Abstract][Full Text] [Related]
31. Melatonin: pharmacological aspects and clinical trends.
Rios ER; Venâncio ET; Rocha NF; Woods DJ; Vasconcelos S; Macedo D; Sousa FC; Fonteles MM
Int J Neurosci; 2010 Sep; 120(9):583-90. PubMed ID: 20707632
[TBL] [Abstract][Full Text] [Related]
32. The role of melatonin in glaucoma: implications concerning pathophysiological relevance and therapeutic potential.
Agorastos A; Huber CG
J Pineal Res; 2011 Jan; 50(1):1-7. PubMed ID: 21073517
[TBL] [Abstract][Full Text] [Related]
33. Binding characteristics and daily rhythms of melatonin receptors are distinct in the retina and the brain areas of the European sea bass retina (Dicentrarchus labrax).
Bayarri MJ; Iigo M; Muñoz-Cueto JA; Isorna E; Delgado MJ; Madrid JA; Sánchez-Vázquez FJ; Alonso-Gómez AL
Brain Res; 2004 Dec; 1029(2):241-50. PubMed ID: 15542079
[TBL] [Abstract][Full Text] [Related]
34. Functional pleiotropy of the neurohormone melatonin: antioxidant protection and neuroendocrine regulation.
Reiter RJ
Front Neuroendocrinol; 1995 Oct; 16(4):383-415. PubMed ID: 8557171
[TBL] [Abstract][Full Text] [Related]
35. Ophthalmic formulations of the intraocular hypotensive melatonin agent 5-MCA-NAT.
Andrés-Guerrero V; Alarma-Estrany P; Molina-Martínez IT; Peral A; Herrero-Vanrell R; Pintor J
Exp Eye Res; 2009 Mar; 88(3):504-11. PubMed ID: 19056382
[TBL] [Abstract][Full Text] [Related]
36. Daily oscillation in melatonin synthesis in the Turkey pineal gland and retina: diurnal and circadian rhythms.
Zawilska JB; Lorenc A; Berezińska M; Vivien-Roels B; Pévet P; Skene DJ
Chronobiol Int; 2006; 23(1-2):341-50. PubMed ID: 16687307
[TBL] [Abstract][Full Text] [Related]
37. Melatonin and its agonists in pain modulation and its clinical application.
Srinivasan V; Zakaria R; Jeet Singh H; Acuna-Castroviejo D
Arch Ital Biol; 2012 Dec; 150(4):274-89. PubMed ID: 23479460
[TBL] [Abstract][Full Text] [Related]
38. The ocular anomalies in a cystinosis animal model mimic disease pathogenesis.
Kalatzis V; Serratrice N; Hippert C; Payet O; Arndt C; Cazevieille C; Maurice T; Hamel C; Malecaze F; Antignac C; Müller A; Kremer EJ
Pediatr Res; 2007 Aug; 62(2):156-62. PubMed ID: 17597652
[TBL] [Abstract][Full Text] [Related]
39. Therapeutic treatments potentially mediated by melatonin receptors: potential clinical uses in the prevention of osteoporosis, cancer and as an adjuvant therapy.
Witt-Enderby PA; Radio NM; Doctor JS; Davis VL
J Pineal Res; 2006 Nov; 41(4):297-305. PubMed ID: 17014686
[TBL] [Abstract][Full Text] [Related]
40. [Melatonin: a popular hormone].
Tarquini B; Perfetto F; Tarquini R
Minerva Med; 1998 May; 89(5):139-51. PubMed ID: 9676179
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
